Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 2 of 2
Full-Text Articles in Entire DC Network
Timing Of Antiretroviral Initiation And Virologic Outcomes Among Hiv-Positive Adults In Ukraine (2010--2015), Yaroslav Zelinskyi
Timing Of Antiretroviral Initiation And Virologic Outcomes Among Hiv-Positive Adults In Ukraine (2010--2015), Yaroslav Zelinskyi
Legacy Theses & Dissertations (2009 - 2024)
Background and introduction:
Safety Assessment For Tipranavir : A Protease Inhibitor Treatment For Hiv Infected Adults, Jaromir Mikl
Safety Assessment For Tipranavir : A Protease Inhibitor Treatment For Hiv Infected Adults, Jaromir Mikl
Legacy Theses & Dissertations (2009 - 2024)
Dose-limiting adverse events associated with anti-retroviral therapy (ART) generally include gastro-intestinal (GI) issues such as vomiting and nausea. However, serious adverse events (SAEs) do occur, the most frequent of which include liver toxicities and renal impairment as well as recent evidence of cardio-vascular disease (CVD) risk.